Seoul
South Korea
5
2014-10-30
5
2014-11-25
These are the the leading inventors for applications assigned to CTI BIO:
CTI BIO based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid
#2 | 2014-06-05 ✅ Patent 8,859,766 granted on 2014-10-14Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid
#3 | 2014-06-05 ✅ Patent 8,884,008 granted on 2014-11-11Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid
#4 | 2012-02-16 ✅ Patent 8,680,253 granted on 2014-03-25Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid
#5 | 2011-07-21 ✅ Patent 8,680,253 granted on 2014-03-25Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid
Also check out CTI Bio's (Seoul, South Korea) applicant profile with 3 patent applications submitted.
67159 ⎘